Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments.
de Vries HJC, Schallig HD.
Am J Clin Dermatol. 2022 Nov;23(6):823-840. doi: 10.1007/s40257-022-00726-8. Epub 2022 Sep 14.
[Cutaneous leishmaniasis].
Mokni M.
Ann Dermatol Venereol. 2019 Mar;146(3):232-246. doi: 10.1016/j.annder.2019.02.002. Epub 2019 Mar 15.
Cutaneous leishmaniasis: A great imitator.
Gurel MS, Tekin B, Uzun S.
Clin Dermatol. 2020 Mar-Apr;38(2):140-151. doi: 10.1016/j.clindermatol.2019.10.008. Epub 2019 Oct 24.
Leishmaniasis.
Burza S, Croft SL, Boelaert M.
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.
Cutaneous leishmaniasis.
Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S.
Lancet Infect Dis. 2007 Sep;7(9):581-96. doi: 10.1016/S1473-3099(07)70209-8.
[Cutaneous leishmaniasis in Germany-still a travel-related disease].
Talas J, Mielcarek K, Wu J, Brunner M, Steinhoff M, Zouboulis CC.
Hautarzt. 2022 Feb;73(2):146-151. doi: 10.1007/s00105-021-04890-6. Epub 2021 Aug 30.
Biomarkers of Cutaneous Leishmaniasis.
Bahrami F, Harandi AM, Rafati S.
Front Cell Infect Microbiol. 2018 Jun 26;8:222. doi: 10.3389/fcimb.2018.00222. eCollection 2018.
Cutaneous Leishmaniasis.
Crecelius EM, Burnett MW.
J Spec Oper Med. 2021 Spring;21(1):113-114. doi: 10.55460/IMV2-JGWD.
Cutaneous leishmaniasis in the 21st century: from the laboratory to the bedside.
Barkati S, Ndao M, Libman M.
Curr Opin Infect Dis. 2019 Oct;32(5):419-425. doi: 10.1097/QCO.0000000000000579.
Cutaneous leishmaniasis in Mali.
Paz C, Doumbia S, Keita S, Sethi A.
Dermatol Clin. 2011 Jan;29(1):75-8. doi: 10.1016/j.det.2010.08.013.
